Malawi to undertake the RTS, S vaccine

Posted on:24 Apr 2019 14:06:07
Malawi to undertake the RTS, S vaccine
24 April 2019 Current Affairs: Malawi, the African Nation, is to undertake large scale pilot tests for the world's most advanced experimental malaria vaccine in a bid to prevent the disease that kills hundreds of thousands across Africa and Asia every year. The RTS, S vaccine, the first to give partial protection to children, trains the immune system to attack the malaria parasite, which is spread by mosquitos.
RTS, S vaccine:
RTS, S vaccine under the trade name Mosquirix has been developed by GlaxoSmithKline, a British pharmaceutical giant,  in partnership with the PATH Malaria Vaccine Initiative. The protein-based RTS, S vaccine went through five years of clinical trials on 15,000 people in seven countries. The vaccine had a lower chance of developing malaria and severe malaria. It is the world's first malaria vaccine that has been shown to provide partial protection against malaria in young children
Even though the potential vaccine does not give full protection against the mosquito-borne disease, it is the furthest along in development and so far the most effective. The pilot tests aim to immunize around 120,000 children aged 2 and below to assess the effectiveness of the pilot vaccine and whether the delivery process is feasible. Malaria which spreads to people through the bites of infected female Anopheles mosquitoes has killed 435,000 people in 2017 alone and the majority of them were children under 5 in Africa.
Republic of Malawi:
Formerly known as Nyasaland
President: Peter Mutharika
Vice-President: Saulos Chilima
Currency: Kwacha (D) (MWK)
Capital: Lilongwe
Malawi, the African Nation, is to undertake large scale pilot tests for the world's most advanced experimental malaria vaccine in a bid to prevent the disease that kills hundreds of thousands across Africa and Asia every year. The RTS, S vaccine, the first to give partial protection to children, trains the immune system to attack the malaria parasite, which is spread by mosquitos.
RTS, S vaccine:
RTS, S vaccine under the trade name Mosquirix has been developed by GlaxoSmithKline, a British pharmaceutical giant,  in partnership with the PATH Malaria Vaccine Initiative. The protein-based RTS, S vaccine went through five years of clinical trials on 15,000 people in seven countries. The vaccine had a lower chance of developing malaria and severe malaria. It is the world's first malaria vaccine that has been shown to provide partial protection against malaria in young children
Even though the potential vaccine does not give full protection against the mosquito-borne disease, it is the furthest along in development and so far the most effective. The pilot tests aim to immunize around 120,000 children aged 2 and below to assess the effectiveness of the pilot vaccine and whether the delivery process is feasible. Malaria which spreads to people through the bites of infected female Anopheles mosquitoes has killed 435,000 people in 2017 alone and the majority of them were children under 5 in Africa.
Republic of Malawi:
Formerly known as Nyasaland
President: Peter Mutharika
Vice-President: Saulos Chilima
Currency: Kwacha (D) (MWK)
Capital: Lilongwe

Monthly Current Affairs



Fresherslive telegram Group

Card image cap

Current Affairs Section



Daily Current Affairs Quiz


Daily Current Affairs Videos Video Link
25th May 2019 Current Affairs Video
24th May 2019 Current Affairs Video
23rd May 2019 Current Affairs Video
22nd May 2019 Current Affairs Video
21st May 2019 Current Affairs Video
Watch more Current Affairs Videos





Subscribe to Current Affairs

Enter your email to get daily current affairs
SUBSCRIBE
Download Current Affairs PDF
Weekly pdf's
60 39
at 21 off

Monthly pdf's
250 125
at 125 off

Yearly pdf's
1200 499
at 701 off

YEARLY Current Affairs PDF

  • Yearly Current Affairs 2018 PDF



  • Currentt Affairs 2019 May

    27 MAY
    NEWS
    26 MAY
    NEWS
    25 MAY
    NEWS
    24 MAY
    NEWS

    Currentt Affairs 2019 April

    30 APRIL
    NEWS
    29 APRIL
    NEWS
    28 APRIL
    NEWS
    27 APRIL
    NEWS

    Currentt Affairs 2019 March

    31 MARCH
    NEWS
    30 MARCH
    NEWS
    29 MARCH
    NEWS
    28 MARCH
    NEWS




    ×
    Download Current Affairs PDF
    Weekly PDF's
    60 39
    at 21 off

    Monthly PDF's
    250 125
    at 125 off

    Yearly PDF's
    1200 499
    at 701 off